協和キリンの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/08/01 | 2,560 | 2,602 | 2,530 | 2,584.5 | -12.5 | -0.5% | 1,719,600 |
2025/07/31 | 2,565.5 | 2,597 | 2,558 | 2,597 | +31.5 | +1.2% | 1,290,300 |
2025/07/30 | 2,560 | 2,582 | 2,556 | 2,565.5 | -17.5 | -0.7% | 1,102,700 |
2025/07/29 | 2,550 | 2,583 | 2,540.5 | 2,583 | +9.5 | +0.4% | 1,204,800 |
2025/07/28 | 2,565 | 2,577.5 | 2,557 | 2,573.5 | +7 | +0.3% | 535,000 |
2025/07/25 | 2,584 | 2,587.5 | 2,559 | 2,566.5 | -7.5 | -0.3% | 621,300 |
2025/07/24 | 2,546 | 2,583.5 | 2,525 | 2,574 | +51.5 | +2% | 940,500 |
2025/07/23 | 2,495.5 | 2,537 | 2,481 | 2,522.5 | +43.5 | +1.8% | 1,060,300 |
2025/07/22 | 2,504.5 | 2,517.5 | 2,464 | 2,479 | -44 | -1.7% | 1,291,800 |
2025/07/18 | 2,540 | 2,540 | 2,511 | 2,523 | -13 | -0.5% | 822,300 |
2025/07/17 | 2,500 | 2,536 | 2,488 | 2,536 | +41.5 | +1.7% | 754,400 |
2025/07/16 | 2,479 | 2,501.5 | 2,476.5 | 2,494.5 | +15.5 | +0.6% | 524,000 |
2025/07/15 | 2,485 | 2,513.5 | 2,471.5 | 2,479 | +4 | +0.2% | 811,500 |
2025/07/14 | 2,467 | 2,496.5 | 2,465 | 2,475 | -5 | -0.2% | 491,800 |
2025/07/11 | 2,489.5 | 2,491.5 | 2,462.5 | 2,480 | -5.5 | -0.2% | 852,600 |
2025/07/10 | 2,499 | 2,505 | 2,473 | 2,485.5 | -21.5 | -0.9% | 1,052,600 |
2025/07/09 | 2,500 | 2,508.5 | 2,486 | 2,507 | +7 | +0.3% | 794,000 |
2025/07/08 | 2,505 | 2,512 | 2,484.5 | 2,500 | -4 | -0.2% | 1,228,700 |
2025/07/07 | 2,520 | 2,529 | 2,493.5 | 2,504 | -9 | -0.4% | 556,600 |
2025/07/04 | 2,493 | 2,513 | 2,486.5 | 2,513 | +20 | +0.8% | 797,300 |
2025/07/03 | 2,486 | 2,509.5 | 2,458 | 2,493 | +10 | +0.4% | 1,435,300 |
2025/07/02 | 2,417.5 | 2,488 | 2,400 | 2,483 | +46 | +1.9% | 1,710,300 |
2025/07/01 | 2,466 | 2,488.5 | 2,434 | 2,437 | -28.5 | -1.2% | 1,270,300 |
2025/06/30 | 2,444.5 | 2,472 | 2,438 | 2,465.5 | +21.5 | +0.9% | 1,065,800 |
2025/06/27 | 2,457.5 | 2,465 | 2,428.5 | 2,444 | -30.5 | -1.2% | 958,400 |
2025/06/26 | 2,475 | 2,487 | 2,464 | 2,474.5 | -0.5 | ±0% | 709,300 |
2025/06/25 | 2,481 | 2,493.5 | 2,451 | 2,475 | -9 | -0.4% | 918,500 |
2025/06/24 | 2,489 | 2,504 | 2,476.5 | 2,484 | +4 | +0.2% | 698,400 |
2025/06/23 | 2,476 | 2,494.5 | 2,456.5 | 2,480 | -2 | -0.1% | 463,600 |
2025/06/20 | 2,479 | 2,488.5 | 2,470 | 2,482 | +3 | +0.1% | 1,367,600 |
2025/06/19 | 2,473 | 2,489.5 | 2,469 | 2,479 | -12 | -0.5% | 514,600 |
2025/06/18 | 2,467 | 2,502 | 2,467 | 2,491 | +11 | +0.4% | 1,028,700 |
2025/06/17 | 2,478.5 | 2,499.5 | 2,469 | 2,480 | -16 | -0.6% | 713,200 |
2025/06/16 | 2,501 | 2,503.5 | 2,465 | 2,496 | +6.5 | +0.3% | 852,800 |
2025/06/13 | 2,497.5 | 2,499 | 2,465.5 | 2,489.5 | ±0 | ±0% | 1,191,900 |
2025/06/12 | 2,471 | 2,497 | 2,463 | 2,489.5 | +12 | +0.5% | 903,600 |
2025/06/11 | 2,487 | 2,494 | 2,461.5 | 2,477.5 | +14.5 | +0.6% | 904,900 |
2025/06/10 | 2,450 | 2,463.5 | 2,434 | 2,463 | +4 | +0.2% | 997,900 |
2025/06/09 | 2,463 | 2,487 | 2,450.5 | 2,459 | +25 | +1% | 794,400 |
2025/06/06 | 2,475 | 2,477.5 | 2,428.5 | 2,434 | -31 | -1.3% | 1,094,200 |
2025/06/05 | 2,447 | 2,488.5 | 2,432 | 2,465 | +82.5 | +3.5% | 1,782,300 |
2025/06/04 | 2,375.5 | 2,397.5 | 2,368.5 | 2,382.5 | +2.5 | +0.1% | 1,020,500 |
2025/06/03 | 2,345.5 | 2,383.5 | 2,313 | 2,380 | +17.5 | +0.7% | 1,302,200 |
2025/06/02 | 2,372.5 | 2,447 | 2,346.5 | 2,362.5 | +9 | +0.4% | 1,972,900 |
2025/05/30 | 2,260 | 2,355.5 | 2,252 | 2,353.5 | +94 | +4.2% | 2,858,900 |
2025/05/29 | 2,261 | 2,293 | 2,257 | 2,259.5 | +5 | +0.2% | 1,143,100 |
2025/05/28 | 2,242 | 2,274 | 2,235.5 | 2,254.5 | +16 | +0.7% | 806,300 |
2025/05/27 | 2,243.5 | 2,248 | 2,221 | 2,238.5 | +11.5 | +0.5% | 913,200 |
2025/05/26 | 2,197.5 | 2,256.5 | 2,187.5 | 2,227 | +24.5 | +1.1% | 970,400 |
2025/05/23 | 2,230 | 2,239 | 2,187 | 2,202.5 | -33 | -1.5% | 1,082,900 |
1~
50
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
協和キリン | 258,400円 | -3.5% | -11.3% | 2.32% | 23.74倍 | 1.61倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
アステラス薬 | 157,600円 | +0.9% | +380.2% | 4.95% | 21.71倍 | 1.87倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,700円 | +20.9% | +10.6% | 2.59% | 12.04倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 425,100円 | +0.1% | -3.4% | 3.76% | 28.90倍 | 1.43倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
小野薬 | 164,100円 | +0.6% | +43.3% | 4.88% | 11.51倍 | 0.99倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム